ACTERO pharmaceutical company is honored to announce the launch of its new scientific product in the field, The Journal of Current Oncology! As the first national English oncology journal, this eclectic review provides you cutting-edge findings in different scopes of clinical oncology collected from top ranking journals and well-known international oncology seminars in order to keep you aware of the recent advancements in the field. As the medical forefronts of the oncology realm which have always conferred credit to us, we hope such scientific work can open a promising avenue to gain the novel insights in your practice in cancer therapy and also better help us persevere to contribute something elegant to the medical society. Actero is a pharmaceutical company specialized in high-quality oncology products and has over 15 products under development or pending Ministry of Health approval.